Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment.
DBA mice were chronically treated with nicotine by continuous intravenous infusion of 4.0 mg/kg/hr for 10 d. Drug-treated mice were tolerant to the acute effects of nicotine on locomotor activity and body temperature. The effect of chronic treatment on the amount of L-3H-nicotine binding and RNA encoding for alpha 4, the most widely expressed nicotinic alpha-subunit, was measured in three brain regions. Chronic treatment increased L-3H-nicotine binding in cortex and midbrain but had no effect in cerebellum. In contrast, chronic treatment had no effect on the levels of mRNA encoding for alpha 4 in any of the three brain regions. Subsequently brains were sectioned and L-3H-nicotine binding was measured using quantitative autoradiographic methods. In addition, the relative amounts of mRNA for the major nicotinic receptor subunits (alpha 4 and beta 2), as well as for three additional minor subunits (alpha 2, alpha 3, and alpha 5), were determined by in situ hybridization histochemistry followed by quantitation of image intensity. Chronic nicotine treatment resulted in increases in the amount of L-3H-nicotine binding in many but not all brain areas measured. In contrast, chronic treatment had little effect on the intensity of the hybridization signal for the nicotinic subunit mRNA. The results suggest that chronic treatment with nicotine under conditions resulting in maximal steady-state increases in L-3H-nicotine binding has little effect on RNA levels encoding any of four nicotinic alpha-subunits and the beta 2-subunit.
Marks
M J
MJ
Institute for Behavioral Genetics, University of Colorado, Boulder 80309.
Pauly
J R
JR
Gross
S D
SD
Deneris
E S
ES
Hermans-Borgmeyer
I
I
Heinemann
S F
SF
Collins
A C
AC
D000818:Animals; D001345:Autoradiography; D001831:Body Temperature / Q000187:drug effects; D001921:Brain / Q000187:drug effects / Q000378:metabolism / Q000502:physiology*; D004334:Drug Administration Schedule; D005260:Female; D007262:Infusions, Intravenous; D007858:Learning / Q000187:drug effects*; D051379:Mice; D008811:Mice, Inbred DBA; D009043:Motor Activity / Q000187:drug effects; D009538:Nicotine / Q000008:administration & dosage / Q000378:metabolism* / Q000494:pharmacology*; D009928:Organ Specificity; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism*; D011978:Receptors, Nicotinic / Q000235:genetics* / Q000378:metabolism*; D012016:Reference Values; D013239:Stereotyped Behavior / Q000187:drug effects; D014316:Tritium
D012333:RNA, Messenger; D011978:Receptors, Nicotinic; D014316:Tritium; D009538:Nicotine